Related Experiment Video
Updated: Mar 29, 2026

A Converging Strategy for the Generation of a Virtually Sequenced cDNA Library from Unreferenced Pacific Oysters
Published on: June 13, 2019
Molecular characterization and functional analysis of tumor necrosis factor receptor-associated factor 2 in the
Baoyu Huang1, Linlin Zhang1, Yishuai Du1
1National & Local Joint Engineering Laboratory of Ecological Mariculture, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China.
Abstract:
Tumor necrosis factor receptor (TNFR)-associated factors (TRAFs) are a family of crucial adaptors, playing vital roles in mediating signal transduction in immune signaling pathways, including RIG-I-like receptor (RLR) signaling pathway. In the present study, a new TRAF family member (CgTRAF2) was identified in the Pacific oyster, Crassostrea gigas. Comparison and phylogenetic analysis revealed that CgTRAF2 could be a new member of the invertebrate TRAF2 family. Quantitative real-time PCR revealed that CgTRAF2 mRNA was highly expressed in the digestive gland, gills, and hemocytes, and it was significantly up-regulated after Vibrio alginolyticus and ostreid herpesvirus 1 (OsHV-1) challenge. The CgTRAF2 mRNA expression profile in different developmental stages of oyster larvae suggested that CgTRAF2 could function in early larval development. CgTRAF2 mRNA expression pattern, after the silence of CgMAVS (Mitochondrial Antiviral Signaling) -like, indicated that CgTRAF2 might function downstream of CgMAVS-like. Moreover, the subcellular localization analysis revealed that CgTRAF2 was localized in cytoplasm, and it may play predominately important roles in signal transduction. Collectively, these results demonstrated that CgTRAF2 might play important roles in the innate immunity and larval development of the Pacific oyster.
Insights
A new gene, CgTRAF2, was discovered in Pacific oysters. This gene is crucial for innate immunity and larval development, showing increased activity when oysters face bacterial and viral challenges.
Area of Science:
- Marine biology
- Immunology
- Genetics
Background:
- Tumor necrosis factor receptor (TNFR)-associated factors (TRAFs) are essential adaptors in immune signaling.
- TRAFs mediate signal transduction in pathways like RIG-I-like receptor (RLR) signaling.
- Understanding TRAF functions is key to marine invertebrate immunity.
Purpose of the Study:
- To identify and characterize a novel TRAF family member in the Pacific oyster, Crassostrea gigas.
- To investigate the role of this new TRAF member in oyster immunity and development.
- To explore its potential involvement in the RIG-I-like receptor signaling pathway.
Main Methods:
- Identification and phylogenetic analysis of CgTRAF2 in Crassostrea gigas.
- Quantitative real-time PCR to analyze CgTRAF2 mRNA expression patterns.
- Subcellular localization studies to determine CgTRAF2's cellular location.
- Gene silencing of CgMAVS-like to infer CgTRAF2's position in signaling pathways.
Main Results:
- A new TRAF family member, CgTRAF2, was identified and confirmed as a potential invertebrate TRAF2.
- CgTRAF2 mRNA showed high expression in digestive glands, gills, and hemocytes.
- Expression significantly increased following Vibrio alginolyticus and ostreid herpesvirus 1 (OsHV-1) challenges.
- CgTRAF2 expression varied during larval development, suggesting a role in early development.
- CgTRAF2 localized to the cytoplasm and appeared to function downstream of CgMAVS-like.
Conclusions:
- CgTRAF2 is a novel TRAF member in the Pacific oyster with significant roles in innate immunity.
- The findings suggest CgTRAF2 is involved in antiviral defense and larval development.
- CgTRAF2 likely plays a critical role in signal transduction pathways within the oyster immune system.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024